SFS
PFE icon

Sharp Financial Services’s Pfizer PFE Stock Holding History

Sharp Financial Services’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$647K Buy
26,883
+4,550
+20% +$119K 0.3% 53
2026
Q1 		$627K Sell
22,333
-456
-2% -$12.1K 0.31% 44
2025
Q4 		$567K Buy
22,789
+1,919
+9% +$48.4K 0.29% 49
2025
Q3 		$532K Buy
20,870
+4,830
+30% +$119K 0.29% 50
2025
Q2 		$389K Sell
16,040
-435
-3% -$10.1K 0.25% 51
2025
Q1 		$417K Buy
16,475
+3,175
+24% +$83.1K 0.32% 44
2024
Q4 		$353K Sell
13,300
-6,700
-34% -$182K 0.27% 58
2024
Q3 		$579K Buy
20,000
+4,649
+30% +$136K 0.45% 38
2024
Q2 		$430K Sell
15,351
-849
-5% -$23.4K 0.37% 49
2024
Q1 		$450K Buy
16,200
+7,188
+80% +$199K 0.42% 48
2023
Q4 		$259K Buy
+9,012
New +$272K 0.28% 66

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Sharp Financial Services's PFE Position: Q2 2026 in Review

Sharp Financial Services increased its Pfizer (PFE) stake by 20% in Q2 2026, buying an estimated $119K and bringing the position to 26,883 shares worth $647K. The position accounts for 0.3% of the portfolio, ranked #53.

Sharp Financial Services first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Sharp Financial Services held 26,883 shares of Pfizer worth $647K as of Q2 2026.
  • Sharp Financial Services bought 4,550 Pfizer shares in Q2 2026, an estimated $119K.
  • Pfizer made up 0.3% of Sharp Financial Services's portfolio in Q2 2026, its #53 holding.
  • Sharp Financial Services first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Sharp Financial Services's 13F filing for Q2 2026, filed 24 Jul 2026.